- Zacks•3 days ago
Merrimack Pharmaceuticals, Inc. (MACK) is scheduled to report fourth-quarter 2016 results in the next week. Last quarter, Merrimack delivered a positive earnings surprise of 23.33%.
- Motley Fool•8 days ago
This biotech hopes to recapture its luster following a major restructuring.
- Motley Fool•9 days ago
Here's why it could make sense for Twitter, GoPro, and Merrimack Pharmaceuticals to get acquired.
MACK : Summary for Merrimack Pharmaceuticals, Inc. - Yahoo Finance
Merrimack Pharmaceuticals, Inc. (MACK)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||3.00 x 500|
|Ask||3.18 x 5600|
|Day's Range||3.15 - 3.23|
|52 Week Range||2.83 - 9.02|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-2.32|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|